News Final judgement favours TwinStrand in Guardant patent case Court issues final judgement in favour of TwinStrand and the University of Washington in their patent infringement suit against Guardant Health.
News Iambic prices its IPO, seeking to raise up to $160m AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.